GSI 7985 (Harvoni ledipasvir 90 mg / sofosbuvir 400 mg)
Generic Name: ledipasvir/sofosbuvir
Pill with imprint GSI 7985 is Orange, Four-sided and has been identified as Harvoni ledipasvir 90 mg / sofosbuvir 400 mg. It is supplied by Gilead Sciences, Inc..
Harvoni is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Harvoni ledipasvir 90 mg / sofosbuvir 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 7985
Harvoni
- Generic Name
- ledipasvir/sofosbuvir
- Imprint
- GSI 7985
- Strength
- ledipasvir 90 mg / sofosbuvir 400 mg
- Color
- Orange
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-1801
More about Harvoni (ledipasvir / sofosbuvir)
- Side Effects
- During Pregnancy
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 391 Reviews
- Drug class: antiviral combinations
- FDA Alerts (2)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.